No Data
Rainmed Medical Reshuffles Joint Company Secretary and Compliance Representative
Rainmed Medical Sets Out Board and Committee Structure
RAINMED-B: ANNUAL REPORT 2025
Runmai Medical-B (02297) announced its 2025 annual performance, with a net loss attributable to shareholders of RMB 77.083 million, narrowing by 32.1% year-on-year.
Runmai Medical-B (02297) announced its annual performance for the fiscal year ended December 31, 2025, with revenue of RMB 19.176 million, representing a year-on-year decrease of 51.8%. The loss attributable to shareholders was RMB 77.083 million, narrowing by 32.1% year-on-year. The basic loss per share was RMB 0.06.
RAINMED-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2025
Rainmed Medical Sets Board Meeting to Approve 2025 Annual Results and Consider Dividend